We have a culture that inspires intellectual curiosity and flexibility.

Counterpoint Global, one of our Active Fundamental Equity teams, seeks to make long-term investments in unique companies whose market value can increase significantly for underlying fundamental reasons. Their portfolios are typically concentrated and differentiated from their benchmarks. Counterpoint Global consists of 56 people, including 32 investors, four disruptive change researchers, two consilient researchers and two sustainability researchers. Counterpoint Global’s culture fosters collaboration, creativity, continued development, and differentiated thinking.

The Counterpoint Global platform includes the Global Opportunity^ investment team, led by Kristian Heugh. 

Counterpoint Global
 
 
 
 
Strategies
LEAD MANAGER: Dennis Lynch
Invests primarily in established and emerging small cap companies in the United States.  
Invests primarily in established and emerging mid cap companies in the United States.  
Invests primarily in established and emerging large cap companies in the United States.  
Invests primarily in established large cap companies in the United States.  
Invests primarily in established and emerging companies in the United States.  
Invests primarily in established and emerging companies globally.  
Invests primarily in established companies in the United States that benefit from efficient scale.  
Invests primarily in established companies globally that benefit from efficient scale.  
Invests primarily in established and emerging companies globally.  
LEAD MANAGER: Kristian Heugh
Invests in high quality established and emerging companies located in Asia (excluding Japan) that the team believes are undervalued at the time of investment.  
Invests in high quality companies located or operating in developing or emerging market countries that the team believes are undervalued at the time of investment.  
Invests in high quality established and emerging companies located in Europe that the team believes are undervalued at the time of investment.  
Invests globally in high quality established and emerging companies that the team believes are undervalued at the time of investment.  
Invests internationally in high quality established companies that the team believes are undervalued at the time of investment.  
Invests internationally in high quality established and emerging companies that the team believes are undervalued at the time of investment.  
Invests globally in high quality companies with strong ESG alignment consistent with the United Nations Sustainable Development Goals that the team believes are undervalued at the time of investment. Restricts businesses operating in industries with material environmental and social externalities and/or corporate governance risk, including alcohol, tobacco, fossil fuels and weapons.  
Invests in high quality companies located or operating in developed market countries that the team believes are undervalued at the time of investment.  
LEAD MANAGER: Manas Gautam
Invests primarily in companies with growing intrinsic value.  
LEAD MANAGERS: Anne Edelstein & Jenny Leeds, Ph.D.
Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.  
 

Subscribe to Counterpoint Global Insights - Consilient Observer

Please enter the code sent to your email address.

Valid for 10 minutes only

Confirm
Email Not Sent
 
 
Submit
 
 
 

^The Global Opportunity team is part of Counterpoint Global with access to shared resources across the platform.

As of March 31, 2022. Team information may change from time to time.

This material is a general communication, which is not impartial and has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. All investments involve risks, including the possible loss of principal. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.


Subscriptions    •    Privacy & Cookies    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037